
FDA In Brief: FDA updates public information about known risk of lymphoma from breast implants
Today, the FDA is communicating updated information about its understanding of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Continue reading.
No hay comentarios:
Publicar un comentario